Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Accriva Diagnostics, Inc. recalls directCHECK ACT-LR whole blood quality control

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Assayed Whole blood control contains labeling with incorrect performance range.
Products
  • directCHECK ACT-LR whole blood quality control
Where it was sold

Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MT, NC, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Hong Kong, Spain.

Nationwide

Units affected
6060
About this recall
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2